ZA07 (Divalproex Sodium Delayed-Release 250 mg)

Pill with imprint ZA07 is White, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Zydus Pharmaceuticals.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA07

Divalproex Sodium Delayed-Release

Imprint

ZA07

Strength

250 mg

Color

White

Size

14.00 mm

Shape

Elliptical / Oval

Availability

Prescription only

Drug Class

Fatty acid derivative anticonvulsants

Pregnancy Category

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine

CSA Schedule

Not a controlled drug

Labeler / Supplier

Zydus Pharmaceuticals

National Drug Code (NDC)

68382-0032

Inactive Ingredients

ammonia, butyl alcohol, microcrystalline cellulose, ferrosoferric oxide, hypromelloses, isopropyl alcohol, magnesium stearate, methacrylic acid, polyethylene glycol, povidone, propylene glycol, shellac, silicon dioxide, sodium starch glycolate type A potato, corn starch, magnesium silicate, triethyl citrate

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer